Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Costello

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical managementSounak Gupta, Sarah H Johnson, George Vasmatzis, et al.
The Journal of Urology|July 31, 2016
Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisHarras B Zaid, William P Parker, Nida S Safdar, et al.
Cancer Medicine|December 13, 2019
Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinomaJeanette E Eckel-Passow, Thai H Ho, Daniel J Serie, et al.
Mayo Clinic Proceedings|March 6, 2012
Germline predictors of androgen deprivation therapy response in advanced prostate cancerManish Kohli, Shaun M Riska, Douglas W Mahoney, et al.
Journal of the National Cancer Institute|October 11, 2023
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminomaDaniel D Joyce, Vidit Sharma, Kevin M Wymer, et al.
The Journal of Urology|June 20, 2023
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell CarcinomaRodrigo Rodrigues Pessoa, Reza Nabavizadeh, Fernando Quevedo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcomeSteven A Schneider, William R Sukov, Igor Frank, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2020
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)Costantine Albany, Travis Dockter, Eric Wolfe, et al.
The Journal of Urology|December 3, 2014
Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer DatabaseMarc C Smaldone, Elizabeth Handorf, Simon P Kim, et al.
Hereditary Cancer in Clinical Practice|May 21, 2011
Factors influencing cancer risk perception in high risk populations: a systematic reviewJon C Tilburt, Katherine M James, Pamela S Sinicrope, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical managementSounak Gupta, Sarah H Johnson, George Vasmatzis, et al.
The Journal of Urology|July 31, 2016
Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisHarras B Zaid, William P Parker, Nida S Safdar, et al.
Cancer Medicine|December 13, 2019
Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinomaJeanette E Eckel-Passow, Thai H Ho, Daniel J Serie, et al.
Mayo Clinic Proceedings|March 6, 2012
Germline predictors of androgen deprivation therapy response in advanced prostate cancerManish Kohli, Shaun M Riska, Douglas W Mahoney, et al.
Journal of the National Cancer Institute|October 11, 2023
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminomaDaniel D Joyce, Vidit Sharma, Kevin M Wymer, et al.
The Journal of Urology|June 20, 2023
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell CarcinomaRodrigo Rodrigues Pessoa, Reza Nabavizadeh, Fernando Quevedo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcomeSteven A Schneider, William R Sukov, Igor Frank, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2020
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)Costantine Albany, Travis Dockter, Eric Wolfe, et al.
The Journal of Urology|December 3, 2014
Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer DatabaseMarc C Smaldone, Elizabeth Handorf, Simon P Kim, et al.
Hereditary Cancer in Clinical Practice|May 21, 2011
Factors influencing cancer risk perception in high risk populations: a systematic reviewJon C Tilburt, Katherine M James, Pamela S Sinicrope, et al.
Pageof 12